Athyrium Opportunities Iv Co-invest 2 Lp - Net Worth and Insider Trading

Athyrium Opportunities Iv Co-invest 2 Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Athyrium Opportunities Iv Co-invest 2 Lp owns 1 companies in total, including RVL Pharmaceuticals PLC (RVLPQ) .

Click here to see the complete history of Athyrium Opportunities Iv Co-invest 2 Lp’s form 4 insider trades.

Insider Ownership Summary of Athyrium Opportunities Iv Co-invest 2 Lp

Ticker	Comapny	Transaction Date	Type of Owner
RVLPQ	RVL Pharmaceuticals PLC	2022-08-08	10 percent owner

Athyrium Opportunities Iv Co-invest 2 Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Athyrium Opportunities Iv Co-invest 2 Lp Ownership Network

Ownership Network List of Athyrium Opportunities Iv Co-invest 2 Lp

No Data

Ownership Network Relation of Athyrium Opportunities Iv Co-invest 2 Lp

Athyrium Opportunities Iv Co-invest 2 Lp Owned Company Details

What does RVL Pharmaceuticals PLC do?

Who are the key executives at RVL Pharmaceuticals PLC?

Athyrium Opportunities Iv Co-invest 2 Lp is the 10 percent owner of RVL Pharmaceuticals PLC. Other key executives at RVL Pharmaceuticals PLC include 10 percent owner Foundation Harsaul , 10 percent owner Altchem Ltd , and director & 10 percent owner David F Burgstahler .

RVL Pharmaceuticals PLC (RVLPQ) Insider Trades Summary

Over the past 18 months, Athyrium Opportunities Iv Co-invest 2 Lp made no insider transaction in RVL Pharmaceuticals PLC (RVLPQ). Other recent insider transactions involving RVL Pharmaceuticals PLC (RVLPQ) include a net sale of 17,544,196 shares made by Altchem Ltd , and a net sale of 17,544,196 shares made by Foundation Harsaul .

In summary, during the past 3 months, insiders sold 0 shares of RVL Pharmaceuticals PLC (RVLPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 35,088,392 shares of RVL Pharmaceuticals PLC (RVLPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 35,088,392 shares.

RVL Pharmaceuticals PLC (RVLPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

RVL Pharmaceuticals PLC Insider Transactions

No Available Data

Athyrium Opportunities Iv Co-invest 2 Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Athyrium Opportunities Iv Co-invest 2 Lp. You might contact Athyrium Opportunities Iv Co-invest 2 Lp via mailing address: 505 Fifth Avenue, Floor 18, New York Ny 10017.

Discussions on Athyrium Opportunities Iv Co-invest 2 Lp

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.